Erlotinib gel (Sol-Gel Technologies)

N/A

Report date: 2026/05/08 20:02:52

Base Information

Drug NameErlotinib gel (Sol-Gel Technologies)
Drug Alias NameSGT-210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsKeratosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSol Gel Technologies Pte Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsKeratosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A